Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: A case of effective industry self-regulation?

International Journal of Drug Policy

Volumn 21, Issue 1, 2010, Pages 86-90

  Wilkins, Chris ^a   Sweetsur, Paul ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

Benzylpiperazine (BZP); Industry self regulation; Legal party pills; Trifluoromethylphenylpiperazine (TFMPP)

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; BENZYLPIPERAZINE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH HAZARD; HEALTH SURVEY; HUMAN; LEGAL ASPECT; LEISURE; MALE; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ALCOHOL DRINKING; DRUG AND NARCOTIC CONTROL; DRUG INDUSTRY; FEMALE; HARM REDUCTION; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; OFF-LABEL USE; PIPERAZINES; YOUNG ADULT;

EID: 71149110538     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.02.005     Document Type: Article

References (18)

1. Baumann M., Clark R., Budzynski A., Partilla J., Blough B., and Rothman K. Effects of "legal X" piperazine analogs on dopamine and serotonin release in rat brain. Annals of the New York Academy of Sciences 1025 (2004) 189-197
2. Baumann M., Clark R., Budzynski A., Partilla J., Blough B., and Rothman R. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Neuropsychopharmacology 30 (2005) 550-560
3. Bye C., Munro-Faure A., Peck A., and Young P. A comparison of the effects of l-benzylpiperazine on human performance tests. European Journal of Clinical Pharmacology 6 (1973) 163-169
4. Campbell H., Cline W., Evans M., et al. Comparison of the effects of dexamethamphetamine and l-benzylpiperazine in former addicts. European Journal of Clinical Pharmacology 6 (1973) 170-176
5. de Boer D., Bosman I., Hidvegi E., Manzoni C., Benko A., dos Reys J., et al. Piperazine-like compounds: A new group of designer drugs of abuse on the European market. Neuropsychopharmacology 30 3 (2005) 550-560
6. Drug Enforcement Administration (DEA) Department of Justice. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final ruling. Federal Register 69 53 (2004) 12794-12797
7. European Monitoring Centre for Drugs and Drug Addiction. (2007). Risk assessment report of a new psychoactive substance: 1-Benzylpiperazine (BZP) (In accordance with Article 6 of Council Decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances). Lisbon.
8. European Monitoring Centre for Drugs and Drug Addiction. (2008). Council decision: 'Appropriate controls' for BZP-new drug BZP to be placed under control across the EU (News Release No 2/2008). Lisbon.
9. Expert Advisory Committee on Drugs. (2004). The expert advisory committee on drugs (EACD) advice to the minister on: Benzylpiperazibe (BZP). Wellington: EACD.
10. Gee P., Richardson S., Woltersdorf W., and Moore G. Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand. New Zealand Medical Journal 118 1227 (2005) 1784
11. New Zealand Herald. (2005). Restraints on party pills delayed (April 2).
12. Sheridan J., Butler R., Wilkins C., and Russell B. Legal piperazine-containing party pills-a new trend in substance misuse. Drug and Alcohol Review 26 (2007) 335-343
13. Social Tonics Association of New Zealand. (2007). Code of practice for restricted substances. November 18, 2008, from http://www.stanz.org.nz/codeofpractice.htm.
14. Theron, L., Jansen, K., & Miles, J. (2007). 'Benzylpiperizine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amphetamines, cocaine, and alcohol. New Zealand Medical Journal, 120(1249), http://www.nzma.org.nz/journal/120-1249/2416/.
15. Vince G. Legally high. New Scientist 191 2571 (2006) 40-45
16. Wilkins C., Girling M., Sweetsur P., Huckle T., and Huakau J. Legal party pill use in New Zealand: Prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and triflourophenylmethylpiperazine (TFMPP) (2006), Centre for Social and Health Outcomes Research and Evaluation (SHORE) & Te Ropu Whariki, Massey University, Auckland
17. Wilkins C., Girling M., and Sweetsur P. The prevalence of use, dependency and harms of legal 'party pills' containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Use 12 (2007) 213
18. Wilkins C., Sweetsur P., and Girling M. Patterns of benzylpiperazine/trifluoromethylphenylpiperazine (BZP/TFMPP) party pill use and adverse effects in a population sample in New Zealand. Drug and Alcohol Review 27 6 (2008) 633-639